A trial looked at when to give focused radiation in some lung cancers
Original title: Deferring or delivering stereotactic radiosurgery in EGFR-mutated non-small cell lung cancer: lessons from the STARLET randomized analysis.
How far along is this research?
- Lab cells
- Animals
- Review
- Tested in people
This was tested in people. That is the most reliable kind of research we share.
It looked at care that doctors already give, in a trial in people, but we have no results yet.
The short version
The full report was not available, so we cannot tell you what it found.
What was studied. The title says this was a randomized analysis called STARLET. It looked at giving focused radiation right away or waiting, in people with a lung cancer that has an EGFR gene change.
What they found. We do not know. No abstract was available for this item. We will not guess at results or numbers the source did not give.
What this means, and what it doesn't
What it could mean: There is nothing here to act on yet. If you have this kind of lung cancer, your care team can talk with you about radiation timing. They can look at the full study when it is available.
What it doesn't mean: This is not a new treatment, and it is not a cure. We have not seen the results, so this does not mean waiting is better, or worse. The timing of focused radiation is a choice doctors weigh case by case. Please do not change your care based on a title alone.
Source: PubMed, September 9, 2026 · Read the original
This plain-language summary was written by AI and published automatically after passing our automatic safety checks. How we write.